Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
We compare Dividend Growth ETFs to reveal the one with the lowest expense ratio, helping you maximize net returns without sacrificing growth.
28,176 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A May 2026 poll defines a new voter cohort—the disillusioned—showing widespread financial strain and a belief that th...
Bitcoin Suisse (Europe) AG has earned a MiCAR-based Crypto Asset Service Provider license, prompting a Europe-wide ex...
Microsoft is reshaping its Xbox division with sweeping layoffs exceeding 3,000 workers, signaling a hard reset that c...
Target’s new chief executive Michael Fiddelke unveils a candor-driven plan to revive growth after a sales slump. The ...
A divorced retiree learns, at age 64, that she can claim up to 50% of her ex-spouse's Social Security record, lifting...
A wave of quantum funding is moving beyond labs to big-name backers. BlackRock, Nvidia, and Temasek are leading a sur...
For the first time ever, Citi Wealth notes a surge in ultrawealthy U.S. clients seeking cross-border diversification ...
Meta Platforms rolls out MTIA chips aimed at infrastructure independence and cost cuts. Analysts weigh whether will c...
Micron Technology and SK Hynix crossed the $1 trillion market-cap milestone this week, joining Samsung as memory gian...
Target is adopting a points-based attendance policy for frontline workers, starting September, with strict penalties ...
CoreWeave’s billion funding haul underscores a shifting liquidity landscape, with AI infrastructure drawing tens of b...